Enorama Pharma AB's total assets for Q3 2025 were kr12.57M, a decrease of ― from the previous quarter. SE:ERMA total liabilities were kr17.22M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.